Tech Company Financing Transactions
Juvaris BioTherapeutics Funding Round
Juvaris BioTherapeutics closed a $15.9 million Series A funding round on 11/2/2007. Investors included Kleiner Perkins Caufield & Byers and private investors.
Transaction Overview
Company Name
Announced On
11/2/2007
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$15,880,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
P.O. Box 208
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
Juvaris BioTherapeutics is a new biotechnology company, started in February, 2003, that is developing potent active immunotherapeutic vaccines. Active immunotherapy involves the activation of the patient's own immune system to combat disease as opposed to passive immunotherapy utilizing administration of preformed monoclonal antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Grant Pickering
Chief Financial Officer
Kimberlee Gonzaga
Browse more venture capital transactions:
Prev: 11/2/2007: Virtual Iron Software venture capital transaction
Next: 11/5/2007: Cilk Arts venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs